CTLA4 and neoplasm: Dual immune check point blockage by anti-CTLA-4 and anti-PD1 in syngeneic mice with NB tumors, resulted in tumor regression and improved OS, which was attributed to increased levels of T cells, NK cells, and inflammatory macrophages [200].